Denali Therapeutics Secures $130,000,000 Series B Financing Round

  • Feed Type
  • Date
    8/26/2016
  • Company Name
    Denali Therapeutics
  • Mailing Address
    151 Oyster Point Blvd. South San Francisco, CA 94080 USA
  • Company Description
    Denali is founded on the collaboration of leading scientists, industry experts and investors who share the vision that scientific discovery energetically applied to translational medicine is the key to delivering effective therapies to patients.
  • Website
    http://www.denalitherapeutics.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $130,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    The company will use the funding to fund its drug candidate pipeline.
  • M&A Terms
  • Venture Investor
    Baillie Gifford
  • Venture Investor
    Undisclosed

Trending on Xconomy